ATXI Avenue Therapeutics
- 3.6600
- +0.0100+0.27%
Avenue Therapeutics News
Avenue Therapeutics Completes Last Patient Last Visit In Phase 1b/2a Clinical Trial Of AJ201 For Spinal And Bulbar Muscular Atrophy
Avenue Therapeutics Completes Last Patient Last Visit In Phase 1b/2a Clinical Trial Of AJ201 For Spinal And Bulbar Muscular Atrophy
Avenue Therapeutics (ATXI.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -15.40 dollars, previous value was -101.57 dollars, and expected value was -9.00 dollars.
Avenue Therapeutics (ATXI.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -15.40 dollars, previous value was -101.57 dollars, and expected value was -9.00 dollars.
Avenue Therapeutics | 10-Q: Quarterly report
Avenue Therapeutics Q1 EPS $(15.40) Misses $(9.00) Estimate
Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate of $(9.00) by 71.11 percent. This is a 85.01 percent increase over losses
Avenue Therapeutics 1Q Loss/Shr $15.40 >ATXI
Avenue Therapeutics 1Q Loss/Shr $15.40 >ATXI
Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent
Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent
Avenue Capital Group Closes on Over $1 Billion in Commitments for European Strategy Targeting Asset-Backed Lending Opportunities
NEW YORK and LONDON, May 9, 2024 /PRNewswire/ -- Avenue Capital Group today announced the successful final closing of the Avenue Europe Special Situations Fund V (the "Avenue Europe Fund"). Together
Avenue Therapeutics Files to Sell 1.42M Shares
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
FLGC, BTOG and CAUD Among Mid-day Movers
Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday's session after the company announced the exercise of warrants for $4.4 million in gross proceeds.These warra
ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings Among Healthcare Movers
Avenue Therapeutics Announces Exercise of Warrants For $4.4M In Gross Proceeds
Avenue Therapeutics Announces Exercise of Warrants For $4.4M In Gross Proceeds
Avenue Therapeutics Shares Are Trading Lower. The Company Recently Announced a 1-for-75 Reverse Stock Split of Its Common Stock.
Avenue Therapeutics Shares Are Trading Lower. The Company Recently Announced a 1-for-75 Reverse Stock Split of Its Common Stock.
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Aon posted adjusted earnings of $5.66 per share, missing ma
Avenue Therapeutics To Carry Out 1-for-75 Reverse Stock Split On April 26th, 2024
April 25th - $Avenue Therapeutics(ATXI.US)$ is about to implement a 1-for-75 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 26th, 2024.$Avenue Therap
Crude Oil Moves Lower; B. Riley Financial Shares Jump
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday.The Dow traded down 0.18% to 38,434.99 while the NASDAQ fell 0.09% to 15,682.38. The S&P 500 als
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday.
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Avenue Therapeutics Inc (NASDAQ:ATXI) shares are trading lower by 28.5% to $0.09 during Wednesday's session after the company announced a reverse stock split.The company is implementing a 1-for-75 rev
Analysis
Price Target
No Data
